The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) is a patient-founded and patient-driven, nonprofit organization that is dedicated to a simple but compelling vision and mission.
OUR VISION: A world without Waldenstrom’s macroglobulinemia (WM).
OUR MISSION: Support and educate everyone affected by WM to improve patient outcomes while advancing the search for a cure.
The IWMF is committed to creating a world without WM by finding a cure. Since 1999, the IWMF has invested over $31 million in WM research projects throughout the world. Thanks to this research, WM patients have better treatment options that can lead to deeper, longer lasting remissions, and fewer side effects.